Searched for
NATIONAL PHARMA PRICING POLICY
India has Rs 95,000 cr addressable market for assistive tech by 2030: NCPEDPIndia's assistive technology market could reach Rs 95,000 crore by 2030 with a dedicated national policy, experts revealed. This sector, cr...- Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
- From export bans to price crashes: Why onion farmers need more than buffer stock purchasesRecent hikes in procurement price have provided little relief, according to stakeholders, as onion farmers argue that prices are still belo...
- Global Market: BOJ policymakers push for faster rate hikes as inflation risks mountThe Bank of Japan is growing more concerned about persistent inflation, with some policymakers advocating faster interest rate hikes after ...
- Rs 1,100 crore a day nightmare: Why FIIs are ruthlessly selling bank stocksForeign investors are aggressively selling Indian bank stocks, offloading over ₹1,100 crore daily due to global economic pressures and port...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- India's defence export boom could hit ₹65,000 crore by 2030; pvt sector startups the real play: Sunil SubramaniamIndia's defence exports are poised to surpass government targets, reaching ₹60,000-65,000 crore by 2030, according to market expert Sunil S...
- RBI MPC: Growth rate could top 7% if oil prices fall furtherThe MPC members had voted for a status quo in the June policy, citing resilient growth and the need to assess inflation impact while statin...
- Drugmakers yet to see gains from government's minimum import price policyGovernment's Minimum Import Price (MIP) initiative to boost domestic drug makers faces a slow start. Despite setting price thresholds for k...
- Sensex rises 291 points, Nifty closes above 24,100; Tech Mahindra, Sun Pharma among top gainersIndian stock markets saw a positive start on Monday, with Sensex and Nifty inching up after Friday's dip. Tech Mahindra led the gains, whil...
- Britain's economic woes fuel discontent with Brexit a decade after historic vote to leave EUA decade after Britain's vote to leave the European Union, business leaders like Simon Boyd and Mike Hawes express frustration. Promises of...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Lower oil prices open door for MPC to time policy normalisation: ICICI ResearchFalling oil prices and easing geopolitical tensions have improved India's inflation outlook, giving the Monetary Policy Committee room to d...
- Did Joe Biden’s ex-medical advisor Fauci fund China’s Wuhan Lab research behind Covid-19 outbreak? Tulsi Gabbard’s final act with ‘never-before-seen’ documents reveals explosive claimsOutgoing Director of National Intelligence Tulsi Gabbard has leveled serious accusations against Anthony Fauci, alleging he funneled US tax...
- US probes Germany's drug pricing policies, opens door to tariffsThe US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and forces the US t...
- Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 crGlobal investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a ...
- Global Markets: Central banks stay vigilant despite oil price relief after US-Iran truceGlobal central banks remain cautious despite easing oil prices following the US-Iran truce. While lower energy costs ease inflation fears, ...
Load More
